Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2012HER2 targeted therapy-induced gastrointestinal toxicity: from the clinical experience to possible molecular mechanismsAl-Dasooqi, N.; Gibson, R.; Bowen, J.; Keefe, D.
2013Matrix metalloproteinases: do they play a role in mucosal pahology of the oral cavity?Al-Azri, A.; Gibson, R.; Keefe, D.; Logan, R.
2015Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositisAl-Azri, A.; Gibson, R.; Bowen, J.; Stringer, A.; Keefe, D.; Logan, R.
2013Systematic review of agents for the management of gastrointestinal mucositis in cancer patientsGibson, R.; Keefe, D.; Lalla, R.; Bateman, E.; Blijlevens, N.; Fijlstra, M.; King, E.; Stringer, A.; van der Velden, W.; Yazbek, R.; Elad, S.; Bowen, J.
2012Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrheaBowen, J.; Mayo, B.; Plews, E.; Bateman, E.; Stringer, A.; Boyle, F.; Finnie, J.; Keefe, D.
2014Determining the mechanisms of lapatinib-induced diarrhoea using a rat modelBowen, J.; Mayo, B.; Plews, E.; Bateman, E.; Wignall, A.; Stringer, A.; Boyle, F.; Keefe, D.
2013Biology of treatment-induced mucositisGibson, R.; Bowen, J.; Bateman, E.; Keefe, D.
2014MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapyLalla, R.; Bowen, J.; Barasch, A.; Elting, L.; Epstein, J.; Keefe, D.; McGuire, D.; Migliorati, C.; Nicolatou-Galitis, O.; Peterson, D.; Raber-Durlacher, J.; Sonis, S.; Elad, S.; The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)
2016Radiotherapy-induced gut toxicity: involvement of matrix metalloproteinases and the intestinal microvasculatureStansborough, R.; Al-dasooqi, N.; Bateman, E.; Keefe, D.; Gibson, R.